Promoter Inactivation or Inhibition by Sequence-specific Methylation and Mechanisms of Reactivation
Overview
Affiliations
In studies on adenovirus promoters, predominantly on the late E2A promoter of adenovirus type 2 (Ad2), we have demonstrated by a number of experimental approaches that the sequence-specific methylation of three 5'-CCGG-3' sequences inactivates this promoter. Recently, we have developed a cell-free transcription system in which the methylation-inactivation of eukaryotic promoters can be studied in detail. It has also been shown that methylation-caused promoter inactivation can be reversed by the 289 amino acid E1A protein of Ad2 or of adenovirus type 5. In the presence of this protein with a transactivating effect, transcription is initiated at the authentic cap site of the methylated late E2A promoter. A similar reactivation of the methylated late E2A promoter can also be effected by a cis-acting genetic element, i.e., the strong enhancer of human cytomegalovirus. Further studies will be directed toward the biochemical mechanisms of promoter silencing by sequence-specific methylations.
Development of an inducible caspase-9 safety switch for pluripotent stem cell-based therapies.
Wu C, Hong S, Winkler T, Spencer D, Jares A, Ichwan B Mol Ther Methods Clin Dev. 2015; 1:14053.
PMID: 26052521 PMC: 4448736. DOI: 10.1038/mtm.2014.53.
Dynamic DNA methylation across diverse human cell lines and tissues.
Varley K, Gertz J, Bowling K, Parker S, Reddy T, Pauli-Behn F Genome Res. 2013; 23(3):555-67.
PMID: 23325432 PMC: 3589544. DOI: 10.1101/gr.147942.112.
Gene therapy for the prevention of vein graft disease.
Southerland K, Frazier S, Bowles D, Milano C, Kontos C Transl Res. 2013; 161(4):321-38.
PMID: 23274305 PMC: 3602161. DOI: 10.1016/j.trsl.2012.12.003.
Bartoszewski R, Jablonsky M, Bartoszewska S, Stevenson L, Dai Q, Kappes J J Biol Chem. 2010; 285(37):28741-8.
PMID: 20628052 PMC: 2937902. DOI: 10.1074/jbc.M110.154575.
Juliger S, Bongartz M, Luty A, Kremsner P, Kun J Immunogenetics. 2003; 54(10):675-80.
PMID: 12557053 DOI: 10.1007/s00251-002-0516-y.